Clinical Trials Logo

Clinical Trial Summary

Injection in the Suprachoroidal space has potential of increasing the efficacy of the drug upto six times with direct effect on retinal tissues sparing the crystalline lens and trabecular meshwork.


Clinical Trial Description

A custom made 30 gauge needle offering 1000 micron penetration of the sclera at the parsplana with the help of gentle pressure on the sclera will help to inject medication such as triamcinilone or VEGF blockade agents (Ziv aflibercept or Bevacizumab) in the potential Suprachoroidal space which offers direct effect of injected drug on the retina and choroid sparing both crystalline lens, trabecular meshwork and other ocular tissues, hence improving efficacy of the drug upto six times and reduce potential complications such as cataract and glaucoma. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03606733
Study type Interventional
Source Marashi Eye Clinic
Contact Ameen Marashi
Phone 963937785557
Email ameenmarashi@hotmail.com
Status Recruiting
Phase N/A
Start date July 1, 2018
Completion date September 1, 2019